Wells Fargo’s Skye Bioscience SKYE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.57K Sell
376
-11,116
-97% -$46.5K ﹤0.01% 5782
2025
Q1
$18.3K Buy
11,492
+293
+3% +$466 ﹤0.01% 5281
2024
Q4
$31.7K Buy
11,199
+3,684
+49% +$10.4K ﹤0.01% 5134
2024
Q3
$29.4K Buy
7,515
+243
+3% +$950 ﹤0.01% 5128
2024
Q2
$58.2K Buy
+7,272
New +$58.2K ﹤0.01% 4874